MBP MAPK Substrate atriptan FK866 also reduces ATP levels

FK866 also reduces ATP levels in ML-2 cells due to the inhibition of NAD synthesis

daily for 4 days)-induced complex III inhibition can be induced in mice for four days in a row without overt hepatotoxicity or lethality

InChi: InChI=1S/C105H156N28O34S5/c1-9-51(6)83(103(164)126-71(105(166)167)35-54-41-112-58-22-14-13-21-56(54)58)132-102(163)82(50(4)5)131-97(158)70(40-81(144)145)124-88(149)61(25-27-76(109)136)117-93(154)66(36-55-42-111-48-113-55)121-101(162)75-45-170-169-44-57(108)85(146)127-72(43-134)98(159)130-73-46-171-172-47-74(100(161)119-64(33-49(2)3)91(152)122-67(37-77(110)137)94(155)120-65(92(153)129-75)34-53-19-11-10-12-20-53)128-89(150)62(26-28-78(138)139)116-86(147)59(23-15-17-30-106)114-96(157)69(39-80(142)143)125-104(165)84(52(7)135)133-90(151)63(29-32-168-8)118-95(156)68(38-79(140)141)123-87(148)60(115-99(73)160)24-16-18-31-107/h10-14

InChiKey: BYWZPUPRVIECEC-UHFFFAOYSA-N

MBP MAPK Substrate atriptan FK866 also reduces ATP levelsMBP MAPK Substrate is used as an exogenous substrate for MAPK. Product information CAS Number: 138028 00 9 Molecular Weight: 1081. 11 Formula: C41H71F3N18O13 Chemical Name: (2S) 2 [(2S) 2 [2 (2 {[(2S) 1 [(2S,3R) 2 [(2S) 2 {[(2S) 1 [(2S) 2 aminopropanoyl]pyrrolidin 2 yl]formamido} 5 [(diaminomethylidene)amino]pentanamido] 3 hydroxybutanoyl]pyrrolidin 2 yl]formamido}acetamido)acetamido] 5 [(diaminomethylidene)amino]pentanamido] 5